SEC Form 5 · accession 0001125345-17-000020
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon Marc Wigginton
Officer — Sr VP, Clinical Dev. & CMO
Period of report
Dec 31, 2016
Accepted (ET)
Feb 8, 2017 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 3, 2016 | S | 10,000 | $29.34 | D | 30,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Due to clerical error, the amount of securities beneficially owned after the transaction on 10/3/16 and reported on a Form 4 on 10/19/16, was incorrect. The corrected amount includes 30,000 Restricted Stock Units (RSU) acquired on 2/25/16 which vest on 2/25/18.